Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation - PubMed (original) (raw)
Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation
David L Schonberg et al. J Neuropathol Exp Neurol. 2007 Dec.
Abstract
Oligodendrocytes are vulnerable to CNS injury and disease. Because oligodendrocytes myelinate CNS axons, their death leads to demyelination and impaired axon conductance, which in turn contribute to neurologic deficits. Replacing oligodendrocytes requires proliferation and differentiation of endogenous NG2+ progenitor cells, a process that can be potently influenced by activated macrophages, which are present in most CNS pathologies. To examine the relationship between oligodendrocyte generation and macrophage activation in vivo, we compared the extent of oligodendrocyte loss and NG2 cell proliferation and differentiation after intraspinal microinjection of lipopolysaccharide (a Toll-like receptor-4 agonist) or zymosan (Toll-like receptor-2 agonist) in rats. Controls included injecting vehicle (sterile PBS; negative control) or lysolecithin (positive control for NG2 cell proliferation and oligodendrocyte differentiation). By 14 days postinjection, lipopolysaccharide injection sites displayed a sigficant rise in NG2 cell proliferation and oligodendrocyte differentiation, which exceeded that in vehicle and lysolecithin injections. Additionally, upregulated ciliary neurotrophic factor expression was present in lipopolysaccharide lesions. In contrast, zymosan-activated macrophages produced complete oligodendrocyte loss without stimulating NG2 cell proliferation, oligodendrocyte replacement, or ciliary neurotrophic factor expression. Zymosan also evoked a delayed lesion expansion and primary demyelination of intact myelinated axons around the lesions. These results clearly delineate the dichotomous potential of macrophage activation for influencing NG2 cell proliferation and oligodendrocyte differentiation. Because endogenous Toll-like receptor ligands are often present in injured CNS tissue, these results shed light on possible mechanisms that restrict oligodendrocyte replacement to specific domains of CNS trauma or disease sites.
Similar articles
- Iron is essential for oligodendrocyte genesis following intraspinal macrophage activation.
Schonberg DL, McTigue DM. Schonberg DL, et al. Exp Neurol. 2009 Jul;218(1):64-74. doi: 10.1016/j.expneurol.2009.04.005. Epub 2009 Apr 15. Exp Neurol. 2009. PMID: 19374902 Free PMC article. - TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
Church JS, Kigerl KA, Lerch JK, Popovich PG, McTigue DM. Church JS, et al. J Neurosci. 2016 Jun 8;36(23):6352-64. doi: 10.1523/JNEUROSCI.0353-16.2016. J Neurosci. 2016. PMID: 27277810 Free PMC article. - E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord.
Church JS, Milich LM, Lerch JK, Popovich PG, McTigue DM. Church JS, et al. Glia. 2017 Jun;65(6):883-899. doi: 10.1002/glia.23132. Epub 2017 Mar 2. Glia. 2017. PMID: 28251686 Free PMC article. - The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS, Blakemore WF. Keirstead HS, et al. Adv Exp Med Biol. 1999;468:183-97. doi: 10.1007/978-1-4615-4685-6_15. Adv Exp Med Biol. 1999. PMID: 10635029 Review. - Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells.
Nishiyama A, Watanabe M, Yang Z, Bu J. Nishiyama A, et al. J Neurocytol. 2002 Jul-Aug;31(6-7):437-55. doi: 10.1023/a:1025783412651. J Neurocytol. 2002. PMID: 14501215 Review.
Cited by
- Chronic demyelination and myelin repair after spinal cord injury in mice: A potential link for glutamatergic axon activity.
Pukos N, Marion CM, Arnold WD, Noble BT, Popovich PG, McTigue DM. Pukos N, et al. Glia. 2023 Sep;71(9):2096-2116. doi: 10.1002/glia.24382. Epub 2023 May 20. Glia. 2023. PMID: 37208933 Free PMC article. - Hidden attributes of zymosan in the pathogenesis of inflammatory diseases: A tale of the fungal agent.
Arya P, Kumar N, Bhandari U, Thapliyal S, Sharma V. Arya P, et al. Iran J Basic Med Sci. 2023 Apr;26(4):380-387. doi: 10.22038/IJBMS.2023.67365.14770. Iran J Basic Med Sci. 2023. PMID: 37009011 Free PMC article. Review. - Leukotrienes vs. Montelukast-Activity, Metabolism, and Toxicity Hints for Repurposing.
Marques CF, Marques MM, Justino GC. Marques CF, et al. Pharmaceuticals (Basel). 2022 Aug 23;15(9):1039. doi: 10.3390/ph15091039. Pharmaceuticals (Basel). 2022. PMID: 36145259 Free PMC article. Review. - NG2-glia crosstalk with microglia in health and disease.
Zhang Z, Li X, Zhou H, Zhou J. Zhang Z, et al. CNS Neurosci Ther. 2022 Nov;28(11):1663-1674. doi: 10.1111/cns.13948. Epub 2022 Aug 23. CNS Neurosci Ther. 2022. PMID: 36000202 Free PMC article. Review. - Toll-like receptors 2 and 4 differentially regulate the self-renewal and differentiation of spinal cord neural precursor cells.
Sanchez-Petidier M, Guerri C, Moreno-Manzano V. Sanchez-Petidier M, et al. Stem Cell Res Ther. 2022 Mar 21;13(1):117. doi: 10.1186/s13287-022-02798-z. Stem Cell Res Ther. 2022. PMID: 35314006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources